Familial and second primary pancreatic cancers: A nationwide epidemiologic study from Sweden
✍ Scribed by Kari Hemminki; Xinjun Li
- Publisher
- John Wiley and Sons
- Year
- 2002
- Tongue
- French
- Weight
- 83 KB
- Volume
- 103
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Familial risk of pancreatic cancer has been mainly assessed through case‐control studies based on reported but not medically verified cancers in family members. We used the nationwide Swedish Family‐Cancer Database on 10.2 million individuals and 21,000 pancreatic cancers to calculate standardized incidence ratios (SIRs) and 95% confidence intervals (CIs) for pancreatic cancer in 0‐ to 66‐year‐old offspring of parents with pancreatic or other specified tumors. Additionally, SIRs for second primary pancreatic cancers were analyzed after any first neoplasm. SIRs for pancreatic cancer (1.68, 95% CI 1.16–2.35) and pancreatic adenocarcinoma (1.73, 95% CI 1.13–2.54) were increased when a parent presented with pancreatic cancer. The risk was not dependent on diagnostic age of offspring or parents. Pancreatic cancer was associated with parental lung, rectal or endometrial cancer and with melanoma. SIRs for pancreatic cancer were 10.01 and 7.96 among offspring who were diagnosed before age 50 years when parents were diagnosed with squamous cell and adenocarcinoma of the lung, respectively, before age 60 years. The population‐attributable proportion of familial pancreatic cancer was 1.1%. Risks for second pancreatic cancers were increased in men and women after small intestinal, colon and bladder cancer. The degree of familial clustering for pancreatic cancer and its population‐attributable proportion were lower than the data cited in the literature. Clustering of pancreatic cancer with sites presenting in hereditary nonpolyposis colorectal cancer was noted. The strong association of pancreatic and lung cancers is puzzling, and it remains unclear to what extent this represents familial sharing of smoking habits. © 2002 Wiley‐Liss, Inc.
📜 SIMILAR VOLUMES
## Abstract A few case‐control studies have been published on familial risks in esophageal cancer. Reliable data on familial risks are needed for prevention and clinical decisions. We used the nation‐wide Swedish Family‐Cancer Database on 10.1 million individuals and close to 6000 esophageal cancer
## Abstract ## BACKGROUND Familial risks in patients with breast carcinoma have not been assessed by morphologic types of medically verified cancers. Reliable data on familial risks would help to establish prevention programs and guide clinical decisions. ## METHODS We used the nationwide Swedis
Carcinoids are rare neuroendocrine tumors, mainly located in the bowel, stomach and lung. Familial risks in carcinoid tumours are not well known apart from multiple endocrine neoplasia 1 (MEN1). We used the nation-wide Swedish Family-Cancer Database on 10.1 million individuals for assessment. Carcin
## Abstract Population attributable factions (PAFs) show the proportion of the disease that could be prevented if the cause could be removed. The PAF for familial breast cancer has not been precisely determined. We used the nationwide Swedish Family‐Cancer Database on 10.2 million individuals and 1